Zinaida Perić
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 5%
Papers in
- Hematology 43
- Hematopoietic Stem Cell Transplantation 34
- Acute Myeloid Leukemia Research 8
-
- Renal Transplantation Outcomes and Treatments 9
Zinaida Perić
59 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 629
- Transplantation 56
- Immunology 417
- Oncology 467
- Genetics 121
Countries citing papers authored by Zinaida Perić
This map shows the geographic impact of Zinaida Perić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zinaida Perić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zinaida Perić more than expected).
Fields of papers citing papers by Zinaida Perić
This network shows the impact of papers produced by Zinaida Perić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zinaida Perić. The network helps show where Zinaida Perić may publish in the future.
Co-authors
The 25 scholars most cited alongside Zinaida Perić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 13 | |
| 11 | 2024 | 27 | |
| 12 | 2023 | 35 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 3 | |
| 16 | 2022 | 41 | |
| 17 | Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 Hit paper breakdown → | 2022 | 159 |
| 18 | 2021 | 17 | |
| 19 | 2020 | 102 | |
| 20 | Diabetes Mellitus Increases the Risk of Serious Infections Following Autologous Stem Cell Transplantation in Patients with Malignant Lymphoma | 2009 | 1 |
About Zinaida Perić
Zinaida Perić is a scholar working on Hematology, Transplantation, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (34 papers), Acute Lymphoblastic Leukemia research (17 papers), Neutropenia and Cancer Infections (12 papers), Renal Transplantation Outcomes and Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Acute Myeloid Leukemia Research (8 papers), CAR-T cell therapy research (8 papers) and Polyomavirus and related diseases (6 papers). The work is most often cited by research in Hematology (629 citations), Transplantation (56 citations), Immunology (417 citations), Oncology (467 citations) and Genetics (121 citations). Zinaida Perić has collaborated with scholars based in Croatia, France and Germany. Frequent co-authors include H. D. Rodger, G. Frerichs, Mohamad Mohty, Grzegorz Basak, Nicolaus Kröger, Ibrahim Yakoub‐Agha, Rafael F. Duarte, John A. Snowden, Raffaella Greco and Hélène Schoemans. Their work appears in journals such as Bone Marrow Transplantation, Blood, Leukemia, Biology of Blood and Marrow Transplantation and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.